Get started
NOVAVAX INCNOVAVAX INCNOVAVAX INC

NOVAVAX INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

NVAX chart


Full chart

Key facts today

Novavax, Inc. will repay $123.8 million to the UK Health Security Agency due to a COVID-19 vaccine supply deal. The refund will occur in quarterly payments of $10.3 million until June 30, 2027.
Analyze the impactAnalyze the impact

NVAX upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪29.39 B‬ MXN
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−48.92 MXN
Net income (FY)
‪−9.26 B‬ MXN
Revenue (FY)
‪16.71 B‬ MXN
Shares float
‪153.03 M‬
Beta (1Y)
2.39

Employees


Employees (FY)
‪1.54 K‬
Change (1Y)
−449 −22.54%
Revenue / Employee (1Y)
‪637.53 K‬ MXN
Net income / Employee (1Y)
‪−353.25 K‬ MXN

About Novavax, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
John C.s Jacobs
Website
novavax.com
Headquarters
Gaithersburg
Founded
1987
FIGI
BBG00W0K8M43
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

NVAX news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

NVAX highest yielding bonds


NVAX5729297
Novavax, Inc. 5.0% 15-DEC-2027
Yield to maturity
3.64%
Maturity date
Dec 15, 2027

Explore more bonds 

Sparks


Curated watchlists where NVAX is featured.

See all sparks 

Frequently Asked Questions


The current price of NVAX is 189.20 MXN — it has increased by 4.82% in the past 24 hours. Watch NOVAVAX INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange NOVAVAX INC stocks are traded under the ticker NVAX.
NVAX stock has fallen by −7.39% compared to the previous week, the month change is a −30.65% fall, over the last year NOVAVAX INC has showed a 57.48% increase.
We've gathered analysts' opinions on NOVAVAX INC future price: according to them, NVAX price has a max estimate of 516.48 MXN and a min estimate of 178.78 MXN. Watch NVAX chart and read a more detailed NOVAVAX INC stock forecast: see what analysts think of NOVAVAX INC and suggest that you do with its stocks.
NVAX reached its all-time high on Feb 9, 2021 with the price of 6,550.10 MXN, and its all-time low was 65.10 MXN and was reached on Feb 6, 2024. View more price dynamics on NVAX chart.
See other stocks reaching their highest and lowest prices.
NVAX stock is 5.25% volatile and has beta coefficient of 2.39. Track NOVAVAX INC stock price on the chart and check out the list of the most volatile stocks — is NOVAVAX INC there?
Today NOVAVAX INC has the market capitalization of ‪29.39 B‬, it has increased by 1.01% over the last week.
Yes, you can track NOVAVAX INC financials in yearly and quarterly reports right on TradingView.
NOVAVAX INC is going to release the next earnings report on Nov 12, 2024. Keep track of upcoming events with our Earnings Calendar.
NVAX earnings for the last quarter are 18.16 MXN per share, whereas the estimation was 30.63 MXN resulting in a −40.72% surprise. The estimated earnings for the next quarter are −16.33 MXN per share. See more details about NOVAVAX INC earnings.
NOVAVAX INC revenue for the last quarter amounts to ‪7.62 B‬ MXN, despite the estimated figure of ‪8.41 B‬ MXN. In the next quarter, revenue is expected to reach ‪1.30 B‬ MXN.
NVAX net income for the last quarter is ‪2.98 B‬ MXN, while the quarter before that showed ‪−2.45 B‬ MXN of net income which accounts for 221.80% change. Track more NOVAVAX INC financial stats to get the full picture.
No, NVAX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 6, 2024, the company has ‪1.54 K‬ employees. See our rating of the largest employees — is NOVAVAX INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOVAVAX INC EBITDA is ‪−4.41 B‬ MXN, and current EBITDA margin is −38.00%. See more stats in NOVAVAX INC financial statements.
Like other stocks, NVAX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVAVAX INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NOVAVAX INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NOVAVAX INC stock shows the neutral signal. See more of NOVAVAX INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.